Organigram confirms additional $2.5 million investment in hyasynth biologicals inc. as biosynthesis pioneer completes first milestone linked to first sale of commercial product and announces executive changes

As an early investor in biosynthesis, organigram holdings inc. (nasdaq: ogi) (tsx: ogi), the parent company of organigram inc. (the “company” or “orga
KFY Ratings Summary
KFY Quant Ranking